Endocrine Therapy Prior Authorization Form — Breast Cancer Treatment and Risk Reduction
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Maine policy alerts
Know when Blue Cross Blue Shield - Maine releases new policies or updates existing guidance.
Monitor payer policy activity
A provider-facing authorization form governing prior authorization requests for select endocrine therapies (anastrozole, exemestane, letrozole, raloxifene, Soltamox, tamoxifen) for Blue Cross Blue Shield - Maine members. It applies to requests for these drugs and documents required clinical information to determine coverage.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.